IDEXX Laboratories Announces Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
IDEXX Labs (IDXX) Tops Q2 EPS by 6c, Revenues Beat; Boosts FY18 EPS Outlook
August 1, 2018 6:35 AM EDTIDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $1.23, $0.06 better than the analyst estimate of $1.17. Revenue for the quarter came in at $580.75 million versus the consensus estimate of $574.55 million.
Reports revenue growth of 14% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 15% reported and 13% organicAchieves 3,241 premium instrument placements, representing 21% year-over-year growthDelivers EPS of $1.23, a 29% increase year-over-year on a reported basis or 33% on a comparable constant currency basisAdjusts 2018 revenue guidance to $2,205 million $2,230 million, reflecting reported growth of... More


